摘要
目的：明确化疗前非小细胞肺癌（ＮＳＣＬＣ）中是否存在原发耐药；是否影响ＮＳＣＬＣ患者的预后。方法：采用Ｓ－Ｐ免疫组化方法，检测９７例化疗前ＮＳＣＬＣ患者中Ｐ－糖蛋白（Ｐｇｐ）的表达情况。结果：Ｐｇｐ在腺癌中高表达，与ＮＳＣＬＣ的淋巴结转移相关；且Ｐｇｐ表达对ＮＳＣＬＣ患者预后有影响。结论：ＮＳＣＬＣ中存在原发耐药，且Ｐｇｐ表达是ＮＳＣＬＣ患者预后的影响因素之一。
Objective: Our paper was designed to explicate whether primary drug resistance exist in untreated patients of nonsmall cell lung carcer (NSCLC) and to analysis whether expressions of Pgp affect theirs prognosis. Methods: S P immunohistochemical method was used to examine expressions of Pgp in 97 samples of primary NSCLC. Results: High expression of Pgp was correlated to lymphnode metastasis and adenocarcinoma. Conclusion: Conclusion: Primary drug resistance might existed in NSCLC and the expression of Pgp might play as a significant prognostic factor for the patients with NSCLC.
出处
《中国医科大学学报》
CAS
CSCD
北大核心
1999年第6期424-425,共2页
Journal of China Medical University
基金
卫生部科研基金!资助项目
98-1-178
关键词
非小细胞肺癌
耐药基因
P-糖蛋白
肺肿瘤
nonsmall cell lung cancer
multidrug resistance gene
prognosis
S P immunohistochemical method
